Selenium Supplementation in Youths With Autoimmune Thyroiditis

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

October 31, 2016

Study Completion Date

August 31, 2018

Conditions
Autoimmune Thyroiditis
Interventions
DIETARY_SUPPLEMENT

L-selenomethionine

The group will be randomized to receive organic selenium in the form of L-selenomethionine at the dose of 200mcg daily (intervention group) for 6 months

OTHER

Placebo

The group will be randomized to receive placebo (control group) for 6 months

Trial Locations (1)

56403

Unit of Pediatric Endocrinology, Diabetes and Metabolism-4th Department of Pediatrics, Medical School of Aristotle University of Thessaloniki, Thessaloniki

All Listed Sponsors
lead

Aristotle University Of Thessaloniki

OTHER

NCT02644707 - Selenium Supplementation in Youths With Autoimmune Thyroiditis | Biotech Hunter | Biotech Hunter